Itoh Shinji, Taketomi Akinobu, Tanaka Shinji, Harimoto Norifumi, Yamashita Yo-ichi, Aishima Shin-ichi, Maeda Takashi, Shirabe Ken, Shimada Mitsuo, Maehara Yoshihiko
Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Mol Cancer Res. 2007 Jul;5(7):667-73. doi: 10.1158/1541-7786.MCR-06-0282.
The human growth factor receptor-bound protein 7 (Grb7) is an adaptor molecule and is related to cell invasion. In this present study, we investigated the clinical and biological significance of Grb7 expression in human hepatocellular carcinoma (HCC). We reviewed 64 consecutive patients who had undergone liver resection for HCC, and we investigated the correlation between Grb7 expression and clinical outcome. To analyze the biological behavior of Grb7 in vitro and in vivo, we established Grb7 stable knockdown HCC cells using RNA interference technology. The positive staining of Grb7 protein was correlated with portal venous invasion (P < 0.01), hepatic venous invasion (P < 0.01), and intrahepatic metastasis (P < 0.05). Positive expression of Grb7 was significantly correlated with focal adhesion kinase (FAK) protein levels in HCC (P < 0.01). The Grb7- and FAK-positive group showed a significantly poorer prognosis as compared with the Grb7- and FAK-negative group (P < 0.05). Grb7 knockdown HCC cells exhibited significantly lower levels of invasion potential (P < 0.05) and motility (P < 0.05) than the control cells in vitro; moreover, Grb7 knockdown HCC cells showed delayed onset of the tumors compared with the control cells in vivo. Grb7 expression can modulate the invasive phenotype of HCC. Grb7 plays an important role in HCC progression and is strongly associated with expression of FAK. Grb7 could be a therapeutic target in HCC.
人类生长因子受体结合蛋白7(Grb7)是一种衔接分子,与细胞侵袭有关。在本研究中,我们调查了Grb7表达在人类肝细胞癌(HCC)中的临床和生物学意义。我们回顾了64例连续接受肝癌肝切除术的患者,并研究了Grb7表达与临床结果之间的相关性。为了分析Grb7在体外和体内的生物学行为,我们使用RNA干扰技术建立了Grb7稳定敲低的肝癌细胞。Grb7蛋白的阳性染色与门静脉侵犯(P < 0.01)、肝静脉侵犯(P < 0.01)和肝内转移(P < 0.05)相关。Grb7的阳性表达与肝癌中粘着斑激酶(FAK)蛋白水平显著相关(P < 0.01)。与Grb7和FAK阴性组相比,Grb7和FAK阳性组的预后明显较差(P < 0.05)。在体外,Grb7敲低的肝癌细胞表现出比对照细胞显著更低的侵袭潜能(P < 0.